Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1972 1
1973 2
1975 3
1976 3
1977 1
1978 2
1979 3
1980 2
1981 1
1983 1
1984 4
1985 1
1986 3
1987 2
1988 1
1989 1
1990 2
1991 2
1992 5
1993 6
1994 4
1995 4
1996 3
1997 6
1998 11
1999 7
2000 4
2001 3
2002 15
2003 10
2004 6
2005 14
2006 12
2007 4
2008 19
2009 8
2010 10
2011 17
2012 14
2013 11
2014 16
2015 19
2016 27
2017 10
2018 11
2019 21
2020 19
2021 18
2022 17
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity"
Page 1
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L. Breijyeh Z, et al. Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117. Toxins (Basel). 2021. PMID: 33562446 Free PMC article. Review.
Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite stimulation and anti-emesis in HIV/AIDS and cancer patients, and for spasticity treatment in multiple sclerosis and epilepsy patient …
Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite …
Best Practices for Intrathecal Baclofen Therapy: Troubleshooting.
Saulino M, Anderson DJ, Doble J, Farid R, Gul F, Konrad P, Boster AL. Saulino M, et al. Neuromodulation. 2016 Aug;19(6):632-41. doi: 10.1111/ner.12467. Epub 2016 Jul 19. Neuromodulation. 2016. PMID: 27434299 Review.
METHODS: An expert panel of 21 multidisciplinary physicians currently managing >3200 ITB patients was convened, and using standard methodologies for guideline development, created an organized approach to troubleshooting ITB. They conducted a structured literature searc …
METHODS: An expert panel of 21 multidisciplinary physicians currently managing >3200 ITB patients was convened, and using standard method …
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E. Solmi M, et al. BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348. BMJ. 2023. PMID: 37648266 Free PMC article. Review.
Cannabidiol improved 50% reduction of seizures (0.59 (0.38 to 0.92)) and seizure events (0.59 (0.36 to 0.96)) (GRADE=high), but increased pneumonia, gastrointestinal adverse events, and somnolence (GRADE=moderate). ...For inflammatory bowel disease, cannabinoids imp …
Cannabidiol improved 50% reduction of seizures (0.59 (0.38 to 0.92)) and seizure events (0.59 (0.36 to 0.96)) (GRADE=high), bu …
Endocrinological Abnormalities in Autism.
De Luca F. De Luca F. Semin Pediatr Neurol. 2020 Oct;35:100582. doi: 10.1016/j.spen.2016.04.001. Epub 2016 Apr 16. Semin Pediatr Neurol. 2020. PMID: 32892953 Review.
A number of chemical messengers, such as various hormones and hormone-like substances, along with neurotransmitters, such as serotonin, dopamine, and norepinephrine, are directly or indirectly linked with the encoding of social behavior via their action at the amygdala, hippocamp …
A number of chemical messengers, such as various hormones and hormone-like substances, along with neurotransmitters, such as serotonin, dopa …
The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools.
Marinho LSR, Chiarantin GMD, Ikebara JM, Cardoso DS, de Lima-Vasconcellos TH, Higa GSV, Ferraz MSA, De Pasquale R, Takada SH, Papes F, Muotri AR, Kihara AH. Marinho LSR, et al. Semin Cell Dev Biol. 2023 Jul 30;144:67-76. doi: 10.1016/j.semcdb.2022.09.007. Epub 2022 Sep 15. Semin Cell Dev Biol. 2023. PMID: 36115764 Review.
In utero exposure to selective serotonin reuptake inhibitors (SSRIs) has been related to developmental abnormalities, including a reduced white matter volume. Several reports have observed an increased incidence of autism spectrum disorder (ASD) and attention defici …
In utero exposure to selective serotonin reuptake inhibitors (SSRIs) has been related to developmental abnormalities, including a red …
Changes Induced by Early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Young Children With Unilateral Cerebral Palsy: A Randomized Clinical Trial.
Araneda R, Ebner-Karestinos D, Paradis J, Klöcker A, Saussez G, Demas J, Bailly R, Bouvier S, Carton de Tournai A, Herman E, Souki A, Le Gal G, Nowak E, Sizonenko SV, Newman CJ, Dinomais M, Riquelme I, Guzzetta A, Brochard S, Bleyenheuft Y. Araneda R, et al. JAMA Pediatr. 2024 Jan 1;178(1):19-28. doi: 10.1001/jamapediatrics.2023.4809. JAMA Pediatr. 2024. PMID: 37930692 Free PMC article. Clinical Trial.
OBJECTIVE: To verify if HABIT-ILE would improve manual abilities in young children with UCP more than usual motor activity. DESIGN, SETTING, AND PARTICIPANTS: This prospective randomized clinical trial (November 2018 to December 2021), including 2 parallel gr …
OBJECTIVE: To verify if HABIT-ILE would improve manual abilities in young children with UCP more than usual motor activity. DESIGN, SETTING, …
Neuroimaging of central nervous system tuberculosis.
Morais CG, Reis-Melo A, Oliveira J, Ribeiro A, Pinto-Carvalho I, Tavares M. Morais CG, et al. Acta Neurol Taiwan. 2023 Jun 30;32(2):86-87. Acta Neurol Taiwan. 2023. PMID: 37198514 Free article.
She started tuberculostatic therapy, but two days later she presented tonic-clonic seizures and impaired consciousness. Cerebral computed tomography (CT) revealed tetrahydrocephalus (Figure 1), needing external ventricular derivation. She had a slow clinical improve …
She started tuberculostatic therapy, but two days later she presented tonic-clonic seizures and impaired consciousness. Cerebral comp …
Adult phenotype of KCNQ2 encephalopathy.
Boets S, Johannesen KM, Destree A, Manti F, Ramantani G, Lesca G, Vercueil L, Koenig MK, Striano P, Møller RS, Cooper E, Weckhuysen S. Boets S, et al. J Med Genet. 2022 Jun;59(6):528-535. doi: 10.1136/jmedgenet-2020-107449. Epub 2021 Apr 2. J Med Genet. 2022. PMID: 33811133
METHODS: We recruited 13 adults (between 18 years and 45 years of age) with KCNQ2 encephalopathy and reviewed their clinical, EEG, neuroimaging and treatment history. RESULTS: While most patients had daily seizures at seizure onset, seizure frequency d …
METHODS: We recruited 13 adults (between 18 years and 45 years of age) with KCNQ2 encephalopathy and reviewed their clinical, EEG, ne …
Cannabis for Pain and Headaches: Primer.
Kim PS, Fishman MA. Kim PS, et al. Curr Pain Headache Rep. 2017 Apr;21(4):19. doi: 10.1007/s11916-017-0619-7. Curr Pain Headache Rep. 2017. PMID: 28281107 Review.
Nabiximols is a cannabis extract that is approved for the treatment of spasticity and intractable pain in Canada and the UK. Further clinical trials are studying the effect of marijuana extracts for seizure disorders. ...
Nabiximols is a cannabis extract that is approved for the treatment of spasticity and intractable pain in Canada and the UK. Further …
Abuse of amphetamines and structural abnormalities in the brain.
Berman S, O'Neill J, Fears S, Bartzokis G, London ED. Berman S, et al. Ann N Y Acad Sci. 2008 Oct;1141:195-220. doi: 10.1196/annals.1441.031. Ann N Y Acad Sci. 2008. PMID: 18991959 Free PMC article. Review.
We review evidence that structural brain abnormalities are associated with abuse of amphetamines. ...Three studies assessed individuals exposed to 3-4-methylenedioxymethamphetamine (MDMA). Brain structural abnormalities were consistently …
We review evidence that structural brain abnormalities are associated with abuse of amphetamines. ...Three studies asse …
362 results